US2015081012A1PendingUtilityA1

Mesh enclosed tissue constructs

Assignee: UNIV CALIFORNIAPriority: Mar 23, 2011Filed: Nov 24, 2014Published: Mar 19, 2015
Est. expiryMar 23, 2031(~4.6 yrs left)· nominal 20-yr term from priority
A61L 27/3804A61K 35/12A61L 2400/18C12N 5/0691C12N 5/0068A61L 27/56A61L 2300/414A61L 27/3808A61L 27/34A61L 2430/20A61L 27/3886C12N 2533/10C12N 2501/15A61F 2240/001A61L 27/54A61F 2/2418A61L 27/3826A61F 2/2415C12N 2533/54A61L 27/047A61L 27/446A61F 2/90A61F 2/07A61K 9/70A61L 27/38A61L 27/3891
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A scaffold to form tissue membranes, comprising: at least one layer of mesh having a first side and a second side, the layer of mesh being either a woven wire metal mesh or a flat metal sheet that is acid-etched such that the layer of mesh includes a network of holes passing directly through the mesh from the first side to the second side; and at least one layer of cells at each side of the mesh enclosing the layer of mesh, such that the at least one layer of cells on the first side interacts with the at least one layer of cells on the second side through the network of holes to provide for structure integration.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A scaffold to form tissue membranes, comprising:
 at least one layer of mesh having a first side and a second side, the layer of mesh being either a woven wire metal mesh or a flat metal sheet that is acid-etched such that the layer of mesh includes a network of holes passing directly through the mesh from the first side to the second side; and   at least one layer of cells at each side of the mesh enclosing the layer of mesh, such that the at least one layer of cells on the first side interacts with the at least one layer of cells on the second side through the network of holes to provide for structure integration.   
     
     
         2 . The scaffold of  claim 1 , wherein the mesh becomes biologically active when implanted in-vivo. 
     
     
         3 . The scaffold of  claim 1 , further comprising a frame attached to the layer of mesh with the at least one layer of cells at each side of the mesh, wherein the frame is formed of a biocompatible metal and is covered with a woven polyester cloth. 
     
     
         4 . The scaffold of  claim 1 , wherein the mesh and at least one layer of cells at each side of the mesh are formed as leaflets, such that the scaffold is operable as a tissue heart valve. 
     
     
         5 . The scaffold of  claim 4 , wherein the scaffold includes at least two leaflets. 
     
     
         6 . The scaffold of  claim 5 , further comprising a flexible frame having a saddle-shaped base with at least two upstanding posts, with the leaflets each having a peripheral free portion and a fixed portion, such that the peripheral free portion extends between the posts and the fixed portion is attached to the base. 
     
     
         7 . The scaffold of  claim 6 , further comprising a frame having a base with three upstanding posts, with the leaflets attached to the frame and between the posts. 
     
     
         8 . The scaffold of  claim 4 , further comprising a flexible frame having a saddle-shaped base with at least two upstanding posts, with the leaflets each having a peripheral free portion and a fixed portion, such that the peripheral free portion extends between the posts and the fixed portion is attached to the base. 
     
     
         9 . The scaffold of  claim 4 , further comprising a frame having a base with three upstanding posts, with the leaflets attached to the frame and between the posts, and wherein the frame is formed of a biocompatible metal and is covered with a woven polyester cloth. 
     
     
         10 . The scaffold of  claim 1 , wherein the layer of mesh is a tubular wire mesh, wherein the at least one layer of cells at each side of the mesh are formed around the mesh to completely or partially conceal the mesh therein, whereby the scaffold is formed in the shape of a vessel to operate as a vascular graft. 
     
     
         11 . The scaffold of  claim 1 , wherein the mesh has a shape of a heart valve leaflet. 
     
     
         12 . The scaffold of  claim 11 , wherein a plurality of leaflets are attached together to form a heart valve shape. 
     
     
         13 . The scaffold of  claim 1 , wherein the mesh is a Nitinol mesh with a thickness between approximately 25 and 76 microns. 
     
     
         14 . The scaffold of  claim 1 , wherein the at least one layer of cells is selected from the group consisting of smooth muscle cells, fibroblast/myofibroblast cells and vascular endothelial cells. 
     
     
         15 . A method for forming a scaffold according to  claim 1 , comprising:
 preparing a layer of mesh having a first side and a second side, the layer of mesh being either a woven wire metal mesh or a flat metal sheet that is acid-etched, such that the layer of mesh comprises a network of holes passing directly through the mesh from the first side to the second side, and   growing a biological matrix around the layer of mesh such that the biological matrix comprises at least one layer of cells at each side of the mesh enclosing the layer of mesh, such that the at least one layer of cells on the first side interacts with the at least one layer of cells on the second side through the network of holes to provide for structure integration.   
     
     
         16 . The method of  claim 15 , wherein the mesh is formed of stainless steel wires, and wherein said preparing the layer of mesh further comprises a preparation technique, or any combination thereof, selected from the group consisting of:
 polishing the layer of mesh;   acid washing the layer of mesh;   ultrasonic clean washing the layer of mesh; and   glow discharging the layer of mesh.   
     
     
         17 . The method of  claim 15 , wherein said preparing the layer of mesh comprises modifying the surface of the mesh by ion beam surface modification to provide a smooth surface and to ensure biocompatibility of the mesh and enhanced cell attachment to said mesh. 
     
     
         18 . The method of  claim 15 , wherein said growing a biological matrix around the layer of mesh comprises modifying the surface of the mesh with an additive to ensure tissue growth. 
     
     
         19 . The method of  claim 18 , wherein the additive is collagen, which applied to the layer of mesh to coat the layer of mesh to promote development of an interconnected pore network. 
     
     
         20 . The method of  claim 15 , wherein said growing a biological matrix around the layer of mesh comprises seeding the at least one layer of cells sequentially on each side of the layer of mesh. 
     
     
         21 . The method of  claim 20 , wherein the sequential seeding of cell layers further comprises adding cytokines, including TGF-β1 with each sequentially seeded layer. 
     
     
         22 . The method of  claim 20 , wherein, if more than one layer of cells is seeded on each side of the mesh, a time interval of approximately two weeks is provided between seeding of each of the different layers of cells. 
     
     
         23 . The method of  claim 15 , wherein the biological matrix is able to further grow and develop when implanted in vivo. 
     
     
         24 . The method of  claim 15 , wherein the biological matrix is grown around the layer of mesh in vitro. 
     
     
         25 . The method of  claim 15 , wherein the layer of mesh is a tubular wire mesh, wherein the at least one layer of cells at each side of the mesh are formed around the mesh to completely or partially conceal the mesh therein, whereby the scaffold is formed in the shape of a vessel to operate as a vascular graft. 
     
     
         26 . The method of  claim 15 , comprising cutting the mesh to the shape of a heart valve leaflet. 
     
     
         27 . The method of claim  35 , comprising attaching a plurality of leaflets together to form a heart valve shape. 
     
     
         28 . The method of  claim 15 , wherein the cells in the at least one layer of cells at each side of the mesh are selected from the group consisting of smooth muscle cells, fibroblast/myofibroblast cells, and vascular endothelial cells.

Join the waitlist — get patent alerts

Track US2015081012A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.